Alfavision Overseas (India) Limited (BOM:531156)
India · Delayed Price · Currency is INR 9.83
-0.49 (-4.75%)
At close: Jul 10, 2026
BOM:531156 Market Cap
BOM:531156 has a market cap or net worth of 309.9 million as of July 10, 2026. Its market cap has increased by 14.44% in one year.
Market Cap
309.90M
Enterprise Value
1.67B
Revenue
19.91M
Ranking
n/a
PE Ratio
245.75
Stock Price
9.83
Market Cap Chart
Since October 21, 2004, BOM:531156's market cap has increased from 14.19M to 309.90M, an increase of 2,084.44%. That is a compound annual growth rate of 15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 309.90M | 65.21% |
| Dec 31, 2025 | 187.58M | -57.19% |
| Dec 31, 2024 | 438.21M | -22.95% |
| Dec 29, 2023 | 568.73M | 43.63% |
| Dec 30, 2022 | 395.97M | 1.01% |
| Dec 31, 2021 | 392.03M | 328.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.47B |
| Smruthi Organics | 1.40B |
| Tyche Industries | 1.25B |
| Krebs Biochemicals & Industries | 1.18B |
| Vasundhara Rasayans | 555.87M |
| Bacil Pharma | 550.87M |
| Crestchem | 393.45M |
| Venmax Drugs and Pharmaceuticals | 223.78M |